General MedicationsINJECTIONStandard
FOSPHENYTOIN SODIUM
FOSPHENYTOIN SODIUM
Standard Dose
EQ 50MG PHENYTOIN NA/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FOSPHENYTOIN SODIUM is listed in Drugs@FDA under application 214926 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FOSPHENYTOIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 50MG PHENYTOIN NA/ML Sponsor GLAND Submission history Latest submission status date: 2023-10-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview FOSPHENYTOIN SODIUM is listed in Drugs@FDA under application 214926 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOSPHENYTOIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 50MG PHENYTOIN NA/ML Sponsor GLAND Submission history Latest submission status date: 2023-10-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.